Olaquindox-induced persistent light reaction treated by Escherichia coli filtrate (Colibiogene)
Willa-Craps
C
C
Elsner
P
P
Burg
G
G
D000822:Animal Husbandry; D009783:Dermatitis, Occupational / Q000188:drug therapy* / Q000209:etiology*; D017454:Dermatitis, Photoallergic / Q000188:drug therapy* / Q000209:etiology*; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004926:Escherichia coli; D005503:Food Additives / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010455:Peptides / Q000008:administration & dosage / Q000627:therapeutic use*; D011810:Quinoxalines / Q000009:adverse effects*
D003879:Dermatologic Agents; D005503:Food Additives; D010455:Peptides; D011810:Quinoxalines; C047752:colibiogen; C013168:olaquindox